Myers Cocktail Injectable Vials Recalled for Sterility Assurance Issues
Olympia Compounding Pharmacy is recalling Myers Cocktail injectable vials due to lack of assurance of sterility. The recall affects approximately 13,679 vials distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for injectable drug with sterility assurance concerns. No illnesses or injuries reported. Sterility issues in injectable medications are high-risk due to direct bloodstream administration, meeting criteria for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Olympia Compounding Pharmacy dba Olympia Pharmacy is recalling Myers Cocktail, a compounded injectable vitamin and mineral preparation distributed in 10 mL single-dose vials. Approximately 13,679 vials are affected.
The recall was initiated due to lack of assurance of sterility. Injectable medications require absolute sterility to prevent contamination and infection. The affected product was distributed nationwide throughout the United States, Puerto Rico, and the U.S. Virgin Islands.
The affected lots and their expiration dates are: L24029 (6/29/2022), A24125-22 (7/25/2022), and A24331-22 (7/31/2022).
The recalled product
- Product
- Myers Cocktail, Magnesium Chloride 9.65 mg/mL Dexpanthenol 4.07 mg/mL Thiamine HCL 1.62 mg/mL Riboflavin-5-Phosphate 3.23 mg/mL Pyridoxine HCL 1.63 mg/mL Niacinamide 1.62 mg/mL Calcium Gluconate 4.07 mg/mL Ascorbic Acid 64.4 mg/mL, Single-Dose 10 mL vial, Rx Only, Olympia Pharmac
- Manufacturer
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Hazard
- injectable-contamination
- sterility-assurance
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: L24029 BUD: 6/29/2022
- A24125-22 BUD: 7/25/2022
- A24331-22 BUD: 7/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27